| Regulatory T cells infiltrate the tumor-induced tertiary lymphoïd structures and are associated with poor clinical outcome in NSCLC P Devi-Marulkar, S Fastenackels, P Karapentiantz, J Goc, C Germain, ... Communications Biology 5 (1), 1416, 2022 | 27 | 2022 |
| Assessment of performance, interpretability, and explainability in artificial intelligence–based health technologies: what healthcare stakeholders need to know L Farah, JM Murris, I Borget, A Guilloux, NM Martelli, SIM Katsahian Mayo Clinic Proceedings: Digital Health 1 (2), 120-138, 2023 | 23* | 2023 |
| Quality of life in patients with BRAF-mutant melanoma receiving the combination encorafenib plus binimetinib: Results from a multicentre, open-label, randomised, phase III … H Gogas, R Dummer, PA Ascierto, A Arance, M Mandalà, G Liszkay, ... European Journal of Cancer 152, 116-128, 2021 | 10 | 2021 |
| Adenoma detection rate is enough to assess endoscopist performance: a population-based observational study of FIT-positive colonoscopies B Denis, I Gendre, N Tuzin, J Murris, A Guignard, P Perrin, G Rahmi Endoscopy International Open 10 (09), E1208-E1217, 2022 | 6 | 2022 |
| Towards filling the gaps around recurrent events in high dimensional framework: a systematic literature review and application J Murris, A Charles-Nelson, A Tadmouri Sellier, A Lavenu, S Katsahian Biostatistics & Epidemiology 7 (1), e2283650, 2023 | 3* | 2023 |
| A systematic review and meta-analysis of incidence of post-thrombotic syndrome, recurrent thromboembolism, and bleeding after upper extremity vein thrombosis O Espitia, A Raimbeau, B Planquette, S Katsahian, O Sanchez, ... Journal of Vascular Surgery: Venous and Lymphatic Disorders, 2023 | 1 | 2023 |
| Prévalence des maladies cutanées visibles: une étude internationale portant sur 13 138 personnes B Cribier, MS Doutre, C Taieb, J Murris, M Saint Aroman, MA Richard, ... Annales de Dermatologie et de Vénéréologie-FMC 1 (8), A295-A296, 2021 | 1 | 2021 |
| Random survival forests for the analysis of recurrent events for right-censored data, with or without a terminal event J Murris, O Bouaziz, M Jakubczak, S Katsahian, A Lavenu | | 2024 |
| Mitigating Text Toxicity with Counterfactual Generation M Bhan, JN Vittaut, N Achache, V Legrand, N Chesneau, A Blangero, ... arXiv preprint arXiv:2405.09948, 2024 | | 2024 |
| Increased levels of GM-CSF and CXCL10 and low CD8+ memory stem T Cell count are markers of immunosenescence and severe COVID-19 in older people J Poisson, C El-Sissy, A Serret-Larmande, N Smith, M Lebraud, JL Augy, ... Immunity & Ageing 21 (1), 28, 2024 | | 2024 |
| A novel methodological framework for the analysis of health trajectories and survival outcomes in heart failure patients J Murris, T Amadei, T Kirscher, A Klein, AI Tropeano, S Katsahian arXiv preprint arXiv:2403.03138, 2024 | | 2024 |
| Risk factors for thromboembolic events in patients hospitalized for COVID-19 pneumonia in a general ward and requiring treatment with oxygen R Degrave, J Murris, A Charles-Nelson, O Hermine, R Porcher, P Ravaud, ... Postgraduate Medical Journal 100 (1180), 120-126, 2024 | | 2024 |
| Evolution of laparoscopic liver surgery in France over the last decade J Deyrat, D Fuks, J Murris, E Lanoy, A Nassar, A Dhote, U Marchese, ... HPB 26, S69, 2024 | | 2024 |
| Protocol for fever control using external cooling in mechanically ventilated patients with septic shock: SEPSISCOOL II randomised controlled trial A Guénégou-Arnoux, J Murris, S Bechet, C Jung, J Auchabie, J Dupeyrat, ... BMJ open 14 (1), e069430, 2024 | | 2024 |
| MSR162 The Curse of Data Maturity in Observational Studies: Practical Advice from Protocol Development to Interpretation of Results J Murris, O Dialla, A Zkik, A Tadmouri Value in Health 26 (12), S424-S425, 2023 | | 2023 |
| P-386 Novel data visualization and unsupervised machine learning techniques to support optimal management of toxicity profiles of encorafenib plus cetuximab in patients with … H Wasan, S Lonardi, J Desai, G Folprecht, C Gallois, EP Marques, S Khan, ... Annals of Oncology 34, S148-S149, 2023 | | 2023 |
| Propagation d'épidémies et survie en grande dimension: des modèles statistiques classiques aux méthodes d'apprentissage A Lavenu Université de Rennes, 2023 | | 2023 |
| Assessment of Performance, Interpretability, and Explainability in Artificial IntelligenceeBased Health Technologies: What Healthcare Stakeholders Need to Know SIM Katsahian | | 2023 |
| MSR4 Data Visualization in Real-World Studies to Aid Understanding and Interpretation J Murris, A Zkik, O Dialla, S Khan, A Tadmouri Value in Health 25 (12), S350, 2022 | | 2022 |
| Corrigendum to'Quality of life in patients with BRAF-mutant melanoma receiving the combination encorafenib plus binimetinib: Results from a multicentre, open-label, randomised … H Gogas, R Dummer, PA Ascierto, A Arance, M Mandalà, G Liszkay, ... European journal of cancer (Oxford, England: 1990) 160, 287-288, 2022 | | 2022 |
